About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cyp27a1tm1Elt
targeted mutation 1, Eran Leitersdorf
MGI:2181406
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Cyp27a1tm1Elt/Cyp27a1tm1Elt B6.129-Cyp27a1tm1Elt/J MGI:5824134
hm2
Cyp27a1tm1Elt/Cyp27a1tm1Elt involves: 129/Sv * C57BL/6J MGI:3621428
cx3
Cyp27a1tm1Elt/Cyp27a1tm1Elt
Cyp2r1tm1(KOMP)Vlcg/Cyp2r1tm1(KOMP)Vlcg
involves: C57BL/6J * C57BL/6N * C57BL/6NTac MGI:5824136


Genotype
MGI:5824134
hm1
Allelic
Composition
Cyp27a1tm1Elt/Cyp27a1tm1Elt
Genetic
Background
B6.129-Cyp27a1tm1Elt/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cyp27a1tm1Elt mutation (1 available); any Cyp27a1 mutation (30 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• serum phosphorus level is decreased slightly from 12.3 mg/dL at 3-5 weeks of age to 10.2 mg/dL on maturity and remains stable thereafter
• mice show a 2- to 3-fold increase in serum 25(OH)D3 level at 6-14 weeks of age, as determined by RIA analysis
• at 10 weeks of age, HPLC analysis revealed that serum 25(OH)D3 values are 52.2 ng/mL versus 19.4 ng/mL in wild-type controls
• in contrast, serum 1,25(OH)2D3 level is comparable to that in wild-type controls (51-68 pg/mL) at 5-16 weeks of age

liver/biliary system
• livers are enlarged by ~45%

growth/size/body
• livers are enlarged by ~45%




Genotype
MGI:3621428
hm2
Allelic
Composition
Cyp27a1tm1Elt/Cyp27a1tm1Elt
Genetic
Background
involves: 129/Sv * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cyp27a1tm1Elt mutation (1 available); any Cyp27a1 mutation (30 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
respiratory system
• slight reduction of cholesterol concentration in the lungs

homeostasis/metabolism
N
• males show normal plasma levels of glucose, corticosterone, ACTH, and testosterone at 3-4 months of age
• 2.5-fold increase in fecal neutral sterol excretion relative to wild-type controls
• severe reduction in intestinal cholesterol absorption (4% from 54% in wild-type controls)
• intestinal cholesterol absorption is restored to normal levels by cholic acid feeding
• concentration of circulating 7-alpha hydroxycholesterol is 4-10 fold higher in null mice
• 2-fold increase in plasma total triacylglycerol levels on a conventional low fat, low cholesterol diet
• plasma triacylglycerol levels are essentially normalized by cholic acid feeding
• marked increase in plasma triacylglycerol levels is confined to the VLDL fraction
• 5-fold increase in cholesterol 7alpha-hydroxylase activity relative to wild-type controls
• bile acid pool size is only 27% of that in wild-type controls
• total bile acid synthesis is about 47% of that in wild-type controls, as measured by the rate of fecal bile acid excretion
• fecal bile acid excretion is about 47% of that in wild-type controls
• slight reduction of cholesterol concentration in the lungs
• 70% increase in hepatic fatty acid synthesis relative to wild-type controls
• marked shift in hepatic fatty acid composition with a ~70% increase in the proportion of oleic (18:1) to stearic acid (18:0)
• hepatic fatty acid synthesis is essentially normalized by cholic acid feeding
• no change in the rates of fatty acid synthesis in adrenal gland, lung, or small intestine tissue
• significant increase of two non-cholesterol sterols, identified as the two forms of lathosterol, in the adrenal glands, not detected in wild-type adrenals
• trace amounts of the two lathosterol forms (~4% of total tissue sterol content) in the lungs, unlike in wild-type controls
• amount of 7 alpha-hydroxycholesterol in liver, kidney and brain is markedly higher in null animals (J:48127)
• 48% increase of cholesterol concentration in the adrenal glands relative to wild-type controls (J:115373)
• marked increase in cholesterol synthesis in the liver and adrenal gland (4-fold), lung (2.9-fold), spleen (2.4-fold), and small intestine (1.8-fold) (J:115373)
• 2.5-fold increase in whole animal cholesterol synthesis relative to wild-type controls, with ~90% attributed to hepatic synthesis (J:115373)
• cholic acid feeding reduces sterol synthesis in the liver and adrenal gland to values significantly below those seen in wild-type mice fed the basal diet alone (J:115373)
• 30% increase in plasma total cholesterols level on a conventional low fat, low cholesterol diet
• marked increase in plasma cholesterol levels is confined to the VLDL fraction
• levels of 25-hydroxyvitamin D are slightly higher in nulls than in wild-type
• 2.4-fold increase in hepatic triacylglycerol levels relative to wild-type controls
• hepatic triacylglycerol levels are essentially normalized by cholic acid feeding

liver/biliary system
• significant hepatomegaly at 3-4 months of age
• hepatomegaly is almost fully reversed by cholic acid or chenodeoxycholic acid feeding
• 40% increase in liver weight relative to wild-type controls
• 2.4-fold increase in hepatic triacylglycerol levels relative to wild-type controls
• hepatic triacylglycerol levels are essentially normalized by cholic acid feeding
• concentration of bile acids in hydrolyzed bile sample from knockout mice is 0.9 mg/ml compared to about 8 mg/ml in a wild-type sample (J:48127)
• molar ratio of cholesterol in gallbladder bile is double that in wild-type controls, due to a significant reduction in bile acid and phospholipid levels while biliary cholesterol concentration remains normal (J:115373)
• bile acid concentration in gallbladder bile is only 37% of that in wild-type controls (J:115373)
• however, bile acid species are similar to those in wild-type controls, with cholic acid predominating in both cases (J:115373)

endocrine/exocrine glands
• upon histology, adrenomegaly reflects cortical cell hypertrophy
• 45% increase in adrenal gland weight relative to wild-type controls
• significantly enlarged adrenal glands at 3-4 months of age
• adrenomegaly is NOT reversed by cholic acid feeding

digestive/alimentary system
• 2.5-fold increase in fecal neutral sterol excretion relative to wild-type controls
• fecal bile acid excretion is about 47% of that in wild-type controls
• severe reduction in intestinal cholesterol absorption (4% from 54% in wild-type controls)
• intestinal cholesterol absorption is restored to normal levels by cholic acid feeding

renal/urinary system
• significant reduction in kidney weight at 3-4 months of age

nervous system
• significant reduction in brain weight at 3-4 months of age

growth/size/body
• significant hepatomegaly at 3-4 months of age
• hepatomegaly is almost fully reversed by cholic acid or chenodeoxycholic acid feeding
• 40% increase in liver weight relative to wild-type controls




Genotype
MGI:5824136
cx3
Allelic
Composition
Cyp27a1tm1Elt/Cyp27a1tm1Elt
Cyp2r1tm1(KOMP)Vlcg/Cyp2r1tm1(KOMP)Vlcg
Genetic
Background
involves: C57BL/6J * C57BL/6N * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cyp27a1tm1Elt mutation (1 available); any Cyp27a1 mutation (30 available)
Cyp2r1tm1(KOMP)Vlcg mutation (0 available); any Cyp2r1 mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• serum phosphorus level is decreased slightly from 12.3 mg/dL at 3-5 weeks of age to 10.2 mg/dL on maturity and remains stable thereafter
• serum 25(OH)D3 level is reduced by more than 50% at 6-14 weeks of age, similar to single Cyp2r1tm1(KOMP)Vlcg homozygotes
• at 10 weeks of age, HPLC analysis revealed that serum 25(OH)D3 values are 5.9 ng/mL versus 5.2 ng/mL in single Cyp2r1tm1(KOMP)Vlcg homozygotes and 19.4 ng/mL in wild-type controls
• in contrast, serum 1,25(OH)2D3 level is comparable to that in wild-type controls (51-68 pg/mL) at 5-16 weeks of age

liver/biliary system
• livers are enlarged by ~35%

skeleton
N
• mice do not develop rickets and show normal serum calcium levels and tibial epiphyseal plates in response to a rachitogenic high-calcium and low-phosphorus diet, consistent with a normal serum concentration of 1,25(OH)2D3

growth/size/body
• livers are enlarged by ~35%





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory